Institute of Biomedical Technologies
- IreportofassessmentexternalelaboratedbythecommissionevaluatordesignatedbytheCommissionEuropeanaftertheendingof theprojectAccording to the call's regulations, projects under the European Commission's (EC) REGPOT program had the option of undergoing an independent assessment of overall research quality and capacity by a committee of international experts appointed by the EC. As stated in the call (European Commission C-2011-5023), “"theresultsofthisassessmentthey mustbediscussedjointlywiththerepresentativesoftheagenciesnationalyauthoritiesrregionalfordeterminetheroadsymethodsfurtherappropriateforpreservethe‘'excellence'’oftheinstitutionbeneficiaryyexplorehiscontributionto thedevelopmentsustainableregionalyEEuropean”. The evaluation will utilize the appropriate resources of the beneficiary institution to facilitate the experts' activities. This will include: (i) Mobilizing available resources and personnel; (ii) Organizing visits by the evaluation committee; (iii) Organizing meetings proposed by the evaluators with members of the project's steering committee and external advisory committee; and (iv) Receiving the results and presenting them to key stakeholders at the regional and national levels. Following the activities carried out by the evaluation committee between March and May 2016, the evaluation results were discussed with various academic and social stakeholders on May 16 and 17, and a summary of the final report and the evaluation committee's recommendations were presented.
- To download the full report, press on This link.
- Executive SummaryThe Scientific Advisory Board (SAB) conducted a comprehensive site visit of the ITB on November 29-31, 2019. During the visit, the SAB attended scientific presentations by the Program leaders and selected Group Leaders and visited the ITB facilities. In addition, the SAB met with postdoctoral and predoctoral researchers. Furthermore, the SAB carried out a closed evaluation session and a final executive session to present recommendations to the ITB Director, Professor Tomás González Hernández and discuss future plans for the ITB. The SAB was impressed by the ITB's accomplishments over the past several years. In particular, by the creation of a biomedical research community with local medical practitioners, and the ITB's success in securing supporting grants and international cooperation.
- To download the full report, press on This link.